M&A TRANSACTION · 2021
RQM+ acquired by Linden Capital Partners
$385.0M· 19.3x EBITDA
Target
RQM+
Acquirer
Linden Capital Partners
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$20.0M
Deal Value
$385.0M
EV/EBITDA
19.3x
Context
This $385.0M acquisition of RQM+ by Linden Capital Partners sits in the medical devices sub-vertical. The 19.3x EBITDA multiple paid in 2021 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Linden Capital Partners is acquiring as a private equity buyer; see how PE acquirers typically price medical devices businesses on our Medical Devices PE buyer-pool page.
Source
Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the RQM+ acquisition.